MND / ALS
Long-term air pollution may raise the risk of motor neurone disease and worsen outcomes after diagnosis, new research suggests. The study, one of the largest to examine this link, tracked 1,463 people newly diagnosed with MND in Sweden, comparing them with over 7,300 population controls and nearly 1,800 sibling controls to account for genetic and [...]
A Leeds Rhinos fan will run 108 miles for motor neurone disease charity in memory of his best friend's mum. Andrew Richardson will take on an ultramarathon from his hometown, Horsforth, to the Yorkshire Three Peaks and back to raise funds for the Motor Neurone Disease Association. The 30-year-old was inspired to attempt the challenge [...]
US$1.04bn agreement for a novel investigational Alzheimer's therapy Biopharma company ADEL has announced that it has entered into an exclusive worldwide license agreement with Sanofi, a multinational healthcare company, for the development and commercialisation of ADEL-Y01. ADEL-Y01 is a potential first-in-class antibody therapy for Alzheimer's disease, and related backup compounds. The total [...]
A new ALS blood test can identify the disease from a single blood draw with 97 per cent accuracy, researchers say. The test can also rule out people who do not have ALS, potentially ending long diagnostic delays. ALS, or amyotrophic lateral sclerosis, is a paralysing disease caused by the death of motor neurones. [...]
Regular exercise is linked to lower disability, fatigue and depression in people with multiple sclerosis, a five-year study has revealed. Other lifestyle factors also supported better outcomes. A higher-quality diet was independently associated with less disability, while not smoking was tied to lower depression scores. The researchers wrote: "These insights may guide personalised [...]
Former rugby league star Kevin Sinfield has completed his 7 in 7: Together challenge, raising £1.15m for MND charities in memory of team-mate Rob Burrow. The former Leeds Rhinos and England rugby league captain arrived at AMT Headingley Stadium after running from York on the final leg of the venture, taking his total raised for [...]
NR Times explores the latest research developments in the world of neurorehabilitation. Shingles vaccine could slow dementia An unusual public health policy in Wales may have produced the strongest evidence yet that a vaccine can reduce the risk of dementia. In a new study led by Stanford Medicine, researchers analysing the health records of Welsh [...]
Researchers are testing whether an mRNA vaccine targeting Epstein-Barr virus could offer a new treatment for multiple sclerosis (MS). The Phase 2 trial will examine how the investigational vaccine affects new MS disease activity, with scientists exploring this approach because EBV is present in almost all people with MS and is believed to play a [...]
A neurologist and geneticist at the University of Sheffield has been appointed to the first Rob Burrow Professorship in Translational Neurobiology named after the late rugby league player Rob Burrow CBE. Funded by the MND Association in honour of its late patron, the Professorship was awarded to Dr Johnathan Cooper-Knock who is based at the [...]
Scientists have discovered a new medicine that they say offers hope of substantially slowing the progress of motor neurone disease (MND). The drug, named M102, works by protecting nerve cells damaged by MND. Preclinical studies of the drug conducted with mice show improvement in movement and nerve function. Researchers are now hopeful the [...]
